Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism POLQ inhibitors(DNA polymerase theta inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
BRCA mutation positive Breast Cancer | Phase 1 | CN | 30 Nov 2024 | |
HRD positive cancer | Phase 1 | CN | 30 Nov 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | CN | 30 Nov 2024 | |
Metastatic Solid Tumor | Phase 1 | CN | 30 Nov 2024 | |
Ovarian Cancer | Phase 1 | CN | 30 Nov 2024 | |
Prostatic Cancer | Phase 1 | CN | 30 Nov 2024 |